Original language | English (US) |
---|---|
Pages (from-to) | 500-505 |
Number of pages | 6 |
Journal | Academic Psychiatry |
Volume | 45 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2021 |
ASJC Scopus subject areas
- Education
- Psychiatry and Mental health
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Academic Psychiatry, Vol. 45, No. 4, 08.2021, p. 500-505.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Psychiatry Milestones 2.0
T2 - Using the Supplemental Guide to Create a Shared Model of the Development of Professional Identity and Expertise
AU - Kinzie, J. Mark
AU - DeJong, Sandra M.
AU - Edgar, Laura
AU - Houston, L. Joy
AU - Janssen, Furhut
AU - Macaluso, Matthew
AU - Aoun, Elie G.
AU - Bowen, Lynneice
AU - Keepers, George
AU - Bentman, Adrienne L.
AU - Cowley, Deborah S.
N1 - Funding Information: Dr. Bentman reports non-financial support from Accreditation Council for Graduate Medical Education (ACGME) - Psychiatry Milestones 2.0 Work Group and non-financial support from ACGME/Psychiatry Review Committee - member, now Vice-Chair, outside the submitted work. Dr. DeJong reports she was Past President of AADPRT when Milestones 2.0 for Psychiatry were developed. Drs. Cowley, Houston, and Kinzie report non-financial support from the Accreditation Council for Graduate Medical Education. Dr. Macaluso has conducted clinical trials research as principal investigator for the following pharmaceutical companies over the last 12 months: (1) Acadia, (2) Allergan, (3) Alkermes, (4) AssureRx/Myriad, (5) Eisai, (6) Lundbeck, (7) Liva Nova, (8) Janssen, (9) Neurim, (10) Otsuka, (11) SAGE pharmaceuticals, and (12) Suven. All clinical trial and study contracts were with and payments made to either the University of Alabama at Birmingham Medical Center or the Kansas University Medical Center Research Institute. From April 2019 to June of 2020, Dr. Macaluso was a member of the speaker bureau for Janssen pharmaceuticals (Spravato/esketamine). Drs. Aoun, Bowen, Edgar, Janssen, and Keepers have nothing to disclose.
PY - 2021/8
Y1 - 2021/8
UR - http://www.scopus.com/inward/record.url?scp=85104830190&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104830190&partnerID=8YFLogxK
U2 - 10.1007/s40596-021-01455-6
DO - 10.1007/s40596-021-01455-6
M3 - Editorial
C2 - 33864231
AN - SCOPUS:85104830190
SN - 1042-9670
VL - 45
SP - 500
EP - 505
JO - Academic Psychiatry
JF - Academic Psychiatry
IS - 4
ER -